Company Overview and News

 
Will Slow GDP Growth Take a Beating on Australia ETFs?

2018-03-12 zacks
Australia’s GDP grew slower than expected by economists, as bad weather led to a fall in exports. Construction activity further dragged down the GDP growth, weighing on gains provided by strong household activity.

 
S&P/ASX 200 closes down 0.7% after 5-day winning run

2018-02-28 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) has closed today just above its low for the day of 6,012.6 ending the index's winning streak.

 
S&P/ASX 200 down 0.4%, AUD lower as China PMI data misses

2018-02-28 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) has failed to rally from its 11.00am low of 6,026 and is hovering around the 6,030 level.

 
S&P/ASX 200 trying to bounce but still down 0.3% around midday

2018-02-28 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) has bounced from its 11.00am low of 6,026 to only be down 20 points around midday.

 
S&P/ASX 200 opens lower as expected, down 0.3% in early trade

2018-02-27 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) has followed in the US markets' footsteps and opened lower this morning.

 
S&P/ASX 200 set to break its winning streak as US rate hike concerns rise

2018-02-27 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) is unlikely to have a sixth consecutive day in the black with futures pointing to a lower start.

 
S&P/ASX 200 opens strongly as expected, up 0.6% in early trade

2018-02-26 proactiveinvestors.com.au
S&P/ASX 200 will look to continue its positive run with ASX 200 futures trading higher, signalling early gains for the ASX 200.

 
S&P/ASX 200 set for another up day as futures run higher

2018-02-26 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) is looking to continue its positive run with ASX 200 futures trading higher, signally early gains for the ASX 200.

 
Quantify Technology Holdings gains certification for Qumulus, improving Amazon features

2018-02-26 proactiveinvestors.com.au
Alexa is the cloud-based voice service from Amazon, and it is the brain behind Amazon Echo and other Alexa-enabled devices.

 
UPDATE 2-JB Hi-Fi's record H1 profit marred by margin worries, shares drop

2018-02-12 reuters
Feb 12 (Reuters) - Australian electronics retailer JB Hi-Fi Ltd posted a record first-half net profit, but spooked investors by warning that earnings growth would slow amid fierce competition, knocking its shares down by more than 8 percent.

 
What to Watch For as Australia's Earnings Season Kicks Off - Bloomberg

2018-02-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
ASX extends losing streak to two sessions as banks weigh

2018-01-11 theage.com.au
Australian shares declined on Thursday as banks weighed the market down, after worries about the future direction of bond markets unsettled Wall Street.

 
ASX extends losing streak to two sessions as banks weigh

2018-01-11 smh.com.au
Australian shares declined on Thursday as banks weighed the market down, after worries about the future direction of bond markets unsettled Wall Street.

 
Consumer Cyclical 'Safer' Dividend December Gains By Tumbling Salem Media Is Broker Favorite

2017-12-26 seekingalpha
Salem Media led Corus Entertainment, GWA Group, and Gamehost as net gain Consumer Cyclical sector favorites per analyst target-price estimates calculated 12/22/17.

 
Australia ETFs in Focus as GDP Growth Misses Expectations

2017-12-07 zacks
Australia’s GDP grew slower than expected by economists, as household spending saw the slowest increase since the 2008 crisis (read: Australia ETFs in Focus on Record Highs).

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...